Procurement
Expert Panel
Create New Account
Login
logo
Report store
Insights
Survey
Consulting
Book discovery call
logo

Transplant Diagnostics Market: Current Analysis and Forecast (2021-2027)

Region:Global

Product Code:UMHE21306

Download Sample Report
Published On

July 2021

Total pages

162

About the Report

Transplant diagnostics are tests used to determine whether the donor and receiver of an organ are compatible before or after a transplant. The demand for transplant diagnostic products is expected to grow mainly due to factors such as the increasing public-private funding for target research activities, the growing burden of infectious diseases, and technological advancements in the field of transplant diagnostics.

The demand for transplant diagnostic products is expected to grow mainly due to factors such as the increasing public-private funding for target research activities, the growing burden of infectious diseases, the increasing number of transplant procedures, and technological advancements in the field of transplant diagnostics. The gap between the demand and supply of organs as demand is always higher than the supply accelerates the transplant diagnostics market growth.

Factors such as reimbursement conflicts and ethical issues in some regions of the world are projected to limit market expansion. Furthermore, the high cost of completing HLA matching utilizing Polymerase Chain Reaction (PCR) and Next-Generation Sequencing (NGS) technologies is impeding the development of the transplant diagnostics market in underdeveloped nations.

Based on technology, the market is fragmented into molecular assay technologies, PCR-based molecular assays, sequencing-based molecular assays, and non-molecular assay technologies. Molecular assay technologies are further categized as PCR-based and sequencing-based molecular assays. The molecular assay technology segment generated revenue of USD XX billion in 2020. The market is expected to grow at a CAGR of XX% during the forecast period to reach a market valuation of USD XX billion by 2027F owing to the increasing public-private financing for target research efforts and the expanding burden of infectious illnesses.

Based on products & services, the market is fragmented into reagents & consumables, instruments, software & services. The instruments segment generated revenue of USD XX million in 2020. The market is expected to grow at a CAGR of XX% during the forecast period to reach a market valuation of USD XX billion by 2027F owing to the increasing healthcare expenditures.

Based on the transplant type, the market is fragmented into solid organ transplantation stem cell transplantation, soft tissue transplantation, bone marrow transplantation. The solid organ transplantation segment generated revenue of USD XX billion in 2020 and is anticipated to reach USD XX billion by the year 2027F, growing at a CAGR of XX% over the forecast period (2021-2027).

Based on the application, the market is fragmented to diagnostic applications and research applications. The diagnostic applications segment generated revenue of USD XX billion in 2020 and is anticipated to reach USD XX million by the year 2027F on account of its varied applications in patient profilin and increasing clinical evidence of its efficacy, growing at a CAGR of XX% over the forecast period (2021-2027).

Based on the end-user, the market is fragmented into independent reference laboratories, hospitals & transplant centers, and research laboratories & academic institutes. The independent reference laboratories segment generated revenue of USD XX billion in 2020 and is anticipated to reach USD XX billion by the year 2027F on account of the growing number of research & development activities outsourced by pharmaceutical & biotechnology companies to independent reference laboratories, growing at a CAGR of XX% over the forecast period (2021-2027).

For a better understanding of the market adoption of the Single Pair Ethernet market, the market is analyzed based on its worldwide penetration in the countries such as North America (United States, Canada, and Rest of North America), Europe (Germany, France, Italy, Spain, United Kingdom and Rest of Europe), Asia-Pacific (China, Japan, India, Australia, and Rest of APAC), and Rest of World. North America constitutes a major market for the Transplant Diagnostics industry and generated revenue of USD XX billion in 2020 and would grow at a CAGR of XX%, owing to the presence of a highly developed healthcare system, high adoption of innovative transplant diagnostic technologies among medical professionals, and the large volume of organ transplantation procedures performed in the region.

Some of the major players operating in the market include TE Connectivity, HARTING, HIROSE, Wurth Electronics, Phoenix Contact, Softing AG, Belden, LEONI, MURR Elektronik, etc. Several M&A's along with partnerships have been undertaken by these players to boost their presence in different regions.

Scope of the Report

Products

Transplant diagnostics are tests used to determine whether the donor and receiver of an organ are compatible before or after a transplant.

Companies

Bio-Rad laboratories, Inc., Dorel Industries Inc., F. Hoffman-La Roche Ltd., QIAGEN N.V., Thermo Fisher Scientific Inc., bioMerieux S.A., Immucor, Inc., llumina, Inc., Luminex Corporation, Becton, Dickinson and Company

Table of Contents

1 MARKET INTRODUCTION

1.1 Market Definitions

1.2 Objective of the Study

1.3 Limitation

1.4 Stake Holders

1.5 Currency Used in Report

1.6 Scope of the Global Transplant Diagnostics Market Study

2 RESEARCH METHODOLOGY OR ASSUMPTION

2.1 Research Methodology for the Global Transplant Diagnostics Market

2.1.1 Main Objective of the Global Transplant Diagnostics Market

3 MARKET SYNOPSIS

4 EXECUTIVE SUMMARY

5 TOP START-UPs UNDER TRANSPLANT DIAGNOSTICS INDUSTRY

6 COVID-19 IMPACT

7 GLOBAL TRANSPLANT DIAGNOSTICS MARKET REVENUE

8 MARKET INSIGHTS BY TECHNOLOGY

8.1 Molecular Assay Technologies

8.1.1 PCR-based molecular assays

8.1.2 Sequencing Based Molecular Assays

8.2 Non-molecular Assays Technology

9 MARKET INSIGHTS BY PRODUCT & SERVICES

9.1 Reagents & Consumables

9.2 Instruments

9.3 Software & Services

10 MARKET INSIGHTS BY TRANSPLANT TYPE

10.1 Solid organ transplantation

10.2 Stem cell transplantation

10.3 Soft tissue transplantation

10.4 Bone marrow transplantation

11 MARKET INSIGHTS BY Application

11.1 Diagnostic application

11.1.1 Pre transplantation diagnostics

11.1.2 Post transplantation diagnostics

11.2 Research Application

12 MARKET INSIGHTS BY End-user

12.1 Independent reference laboratories

12.2 Hospitals & transplants ceneters

12.3 Research laboratories & Academic institutes

11 MARKET INSIGHTS BY REGION

11.1 NORTH AMERICA TRANSPLANT DIAGNOSTICS MARKET

11.1.1 United States

11.1.2 Canada

11.1.3 Rest of North America

11.2 EUROPE TRANSPLANT DIAGNOSTICS MARKET

11.2.1 Germany

11.2.2 France

11.2.3 United Kingdom

11.2.4 Spain

11.2.5 Italy

11.2.6 Rest of Europe

11.3 ASIA PACIFIC TRANSPLANT DIAGNOSTICS MARKET

11.3.1 China

11.3.2 Japan

11.3.3 India

11.3.4 Australia

11.3.5 South Korea

11.3.6 Rest of Asia Pacific

11.4 REST OF THE WORLD TRANSPLANT DIAGNOSTICS MARKET

12 BABY MONITOR MARKET DYNAMICS

12.1 Market Drivers

12.2 Market Challenges

12.3 Impact Analysis

13 LEGAL & REGULATORY FRAMEWORK

14 DEMAND AND SUPPLY SIDE ANALYSIS

14.1 Demand Side Analysis

14.2 Supply Side Analysis

14.2.1 Top Product Launches

14.2.2 Top Business Partnerships

14.2.3 Top Merger & Acquisitions

15 VALUE CHAIN ANALYSIS

16 TRANSPLANT DIAGNOSTICS MARKET OPPORTUNITIES

17 TRANSPLANT DIAGNOSTICS MARKET TRENDS & INSIGHTS

18 COMPETITIVE SCENARIO

18.1 Porter's Five forces analysis

18.1.1 Bargaining power of Supplier

18.1.2 Bargaining power of Buyer

18.1.3 Industry Rivalry

18.1.4 Availability of Substitute

18.1.5 Threat of new Entrants

19 COMPANY PROFILED

19.1 Bio-Rad laboratories, Inc.

19.1.1 Key Facts

19.1.2 Business Description

19.1.3 Key Product/Services Offerings

19.1.4 Growth Strategy

19.1.5 SWOT Analysis

19.1.6 Key Financials

19.1.6.1 Revenue Split

19.1.6.2 Financial Overview of Bio-Rad laboratories, Inc.

19.1.7 Recent Developments

19.1.7.1 Product Launch

19.1.7.2 Partnerships

19.1.7.3 Business Expansion and Investments

19.1.7.4 Merger and Acquisition

19.2 Dorel Industries Inc.

19.3 F. Hoffman-La Roche Ltd.

19.4 QIAGEN N.V.

19.5 Thermo Fisher Scientific Inc.

19.6 bioMerieux S.A.

19.7 Immucor, Inc.

19.8 llumina, Inc.

19.9 Luminex Corporation

19.10 Becton, Dickinson and Company

20 DISCLAIMER

Research Methodology

Why Buy From Us?

RRR
Refine Robust Result (RRR) Framework

What makes us stand out is that our consultants follows Robust, Refine and Result (RRR) methodology. i.e. Robust for clear definitions, approaches and sanity checking, Refine for differentiating respondents facts and opinions and Result for presenting data with story

reach
Our Reach Is Unmatched

We have set a benchmark in the industry by offering our clients with syndicated and customized market research reports featuring coverage of entire market as well as meticulous research and analyst insights.

Research
Shifting the Research Paradigm

While we don't replace traditional research, we flip the method upside down. Our dual approach of Top Bottom & Bottom Top ensures quality deliverable by not just verifying company fundamentals but also looking at the sector and macroeconomic factors.

Insite
More Insights-Better Decisions

With one step in the future, our research team constantly tries to show you the bigger picture. We help with some of the tough questions you may encounter along the way: How is the industry positioned? Best marketing channel? KPI's of competitors? By aligning every element, we help maximize success.

Trust
Transparency and Trust

Our report gives you instant access to the answers and sources that other companies might choose to hide. We elaborate each steps of research methodology we have used and showcase you the sample size to earn your trust.

support
Round the Clock Support

If you need any support, we are here! We pride ourselves on universe strength, data quality, and quick, friendly, and professional service.

Why Client Choose Us?

400000+ Reports in repository
150+ Consulting project a year
100+ Analysts
8000+ Client Queries in 2022